Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Psoriatic Arthritis Psoriatic Arthritis for November/December 2020 Synovial, skin gene expression differences may explain PsA treatment responses, More must reads Psoriatic Arthritis for September/October 2020 Guselkumab improvements for psoriatic arthritis persist through 1 year, More must readsPsoriatic Arthritis for July/August 2020 Biologics may delay psoriatic arthritis, study finds, PASDAS beats DAS28 in measuring psoriatic arthritis treat-to-target success, More must readsPsoriatic Arthritis for May/June 2020 Entheseal lesions, bone density linked with incident PsA in psoriasis patients, TNF inhibitor plus methotrexate surpassed methotrexate monotherapy in PsA, Biologics better solo than with methotrexate in psoriatic arthritis, More must readsPsoriatic Arthritis for March/April 2020 Financial incentives affect the adoption of biosimilars, Genome study examines heritability of psoriatic disease subtypes, Rapid shift to adalimumab biosimilars in Denmark contrasts with U.S. experience, AAD-NPF releases first guidelines for nonbiologic treatments of psoriasis, More must readsPages1 2 3 last ยป
